Novo Nordisk | NVO - Себестоимость

Биржевая цена
36.83
Изменение за день
-0.20 -0.54%
Ежемесячно
-7.07%
Ежегодный
-52.07%
Q1 прогноз
34.66




Себестоимость Изменить Дата
ANI Pharmaceuticals USD 122.88M 6.86M 2025-12
Aurora Cannabis CAD 88.61M 30.53M 2025-12
Bausch Health Companies USD 1.03B 284M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Canopy Growth CAD 53.08M 8.3M 2025-12
Corcept Therapeutics USD 2.54M 2.05M 2025-12
Drreddys Laboratories INR 40.46B 3.64B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Merck USD 3.32B 531M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Novartis USD 3.54B 3M 2025-12
Novo Nordisk DKK 15.15B 2.3B 2025-12
Novo Nordisk DKK 1.95B 10.94B 2025-06
Pacira USD 54.62M 6.02M 2025-12
Perrigo USD 747.4M 81.2M 2025-12
Phibro Animal Health USD 240.42M 2.58M 2025-12
Prestige Brands USD 131.22M 3.52M 2025-12
Sanofi EUR 4.29B 421M 2025-12
Supernus Pharmaceuticals USD 47.53M 4.24M 2025-12
Zoetis USD 743M 60M 2025-12